Zydus Lifesciences Ltd announced on Friday that the United States Food and Drug Administration (USFDA) has successfully completed an inspection of its Ahmedabad facility without...
Shilpa Medicare, in partnership with the Zydus Group through their joint venture Oncosol, and its collaborator Shorla Oncology, announced on November 27 that the USFDA...
Shares of Zydus Lifesciences Ltd. ended flat after hitting a day’s high of Rs 1,070.50 on 11th October, despite the firm announcing yesterday that it...
Shares of Zydus Lifesciences were trading in the red and 1% lower on 3 October despite the company announced receiving tentative approval from the US...
Shares of Zydus Lifesciences were trading higher by 1% on 1 October after the company announced that it had received an ‘Establishment Inspection Report (EIR)’...
Shares of Zydus Lifesciences Ltd saw a 1% increase during the early trading hours on 30 September after the company announced receiving final approval from...